Three Peaks Capital Management’s ICU Medical ICUI Stock Holding History

Three Peaks Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,330	Closed	-$1.86M	–	147
2018 Q2	$1.86M	Buy	+6,330	New	+$1.73M	0.37%	108

Other funds holding ICUI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Three Peaks Capital Management's ICUI Position: Q3 2018 in Review

Three Peaks Capital Management sold out of ICU Medical (ICUI) in Q3 2018, closing a stake of 6,330 shares — an estimated $1.86M sold.

Three Peaks Capital Management first reported a position in ICUI in Q2 2018 and held it in 1 quarter. The position peaked at $1.86M in Q2 2018. 352 funds tracked by Wall St. Rank hold ICUI as of Q3 2018.

Three Peaks Capital Management reported no remaining ICU Medical position as of Q3 2018 after selling out during the quarter.
Three Peaks Capital Management sold 6,330 ICU Medical shares in Q3 2018, an estimated $1.86M.
Three Peaks Capital Management first reported a position in ICU Medical in Q2 2018 and held it in 1 quarter.
Three Peaks Capital Management's ICU Medical position peaked at $1.86M in Q2 2018.
352 funds tracked by Wall St. Rank held ICU Medical as of Q3 2018.

Based on Three Peaks Capital Management's 13F filing for Q3 2018, filed 23 Oct 2018.